Status:
UNKNOWN
Light-CT in the Diagnosis of Breast Tumor and Lymph Node
Lead Sponsor:
Peking University People's Hospital
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-90 years
Brief Summary
Intraoperative pathological diagnosis such as frozen section and imprint cytology is not routinely recommended in clinical practice because of time and accuracy concerns. Full-field optical coherence ...
Detailed Description
Light-CT, a special-designed pathology-approximation system which is based on the lighting feature or dynamic feature of tissue and cells, is used to detect malignant cells or tissue in fresh specimen...
Eligibility Criteria
Inclusion
- Patients planning to undergoing breast surgery/surgical lymph node staging.
- Specimen could be obtained.
Exclusion
- Prior open biopsy
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03791853
Start Date
April 1 2018
End Date
December 31 2023
Last Update
December 21 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Breast Center, Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044
2
Beijing Chaoyang Hospital
Beijing, China, 100000
3
Xuanwu Hospital of Capital Medical University
Beijing, China, 100000